Hospice Market - Global Forecast 2025-2032

The United States hospice care market is experiencing significant changes as demand for compassionate, patient-centered end-of-life services accelerates amid shifting demographics, regulatory updates, and advancing healthcare technology.

Hospice Market Snapshot

The hospice market in the United States expanded from USD 129.67 billion in 2024 to USD 139.59 billion in 2025 and is expected to reach USD 240.82 billion by 2032, marking a robust compound annual growth rate. This sustained uptick highlights the increasing importance of holistic end-of-life care, which is shaped by the growing needs of older populations, innovations in healthcare policy, and the growing role of digital health solutions such as telemedicine and remote patient monitoring. Rising rates of chronic disease and the adoption of value-based care frameworks are prompting providers to enhance the breadth and quality of hospice offerings for diverse patient populations.

Scope & Segmentation of the Hospice Care Market

This report provides a detailed breakdown of the United States hospice market, delivering a nuanced analysis of emergent trends, geographic variation, market drivers, and the competitive scenario. Executives and industry leaders will find segmentation insights that support strategic and targeted approaches to expansion and operational excellence.

• Service Types: Counselling services, medical supplies, nursing and physician services, all integral to comprehensive hospice programs that address both physical and emotional patient needs.
• Care Types: Options including continuous home care, general inpatient care, inpatient respite care, and routine home care, ensuring flexibility to address differing levels and contexts of care intensity.
• Applications: Facility-based care delivered in hospice centers, hospitals, and skilled nursing facilities, alongside growing emphasis on home-based models which foster family involvement and comfort.
• Patient Conditions: Tailored care for patients with cancer, cardiovascular conditions, chronic kidney disease, HIV/AIDS, neurological disorders, and respiratory diseases, allowing for specialized pathways and protocols.
• Regional Coverage: Comprehensive analytic insights are provided for regions including the Americas, Europe, Middle East & Africa, and Asia-Pacific to account for regulatory, economic, and cultural influences.
• Key Companies: Market innovation and consolidation are being propelled by providers such as AccentCare Inc., Amedisys Inc., Gentiva, Heart to Heart Hospice, Humana Inc., VITAS Healthcare by Chemed Corporation, and Elara Caring, among others.

Key Takeaways for Senior Decision-Makers

• Changing population dynamics and an increased focus on chronic disease management are elevating demand for personalized hospice care, particularly for patients and families prioritizing meaningful end-of-life experiences.
• Progressive healthcare policy is driving transitions toward value-based reimbursement models, supporting earlier hospice referrals and reinforcing interdisciplinary care coordination.
• Adoption of digital health technologies is enabling more consistent pain management, reducing administrative burdens, and reaching underserved communities with targeted care resources.
• Emphasis on home-based and patient-preference-driven care models is enhancing quality of life, with increased support from volunteer and local community networks.
• Persistent workforce challenges, such as recruitment, retention, and the need for specialized training, are prompting organizations to implement flexible staffing solutions, mentorship, and continuous professional development programs.

Tariff Impact on Hospice Supply Chains

Recent tariffs on imported medical supplies as of 2025 have increased costs for essential equipment and consumables in hospice care. Providers are responding by strengthening domestic supplier partnerships, evaluating alternative sourcing regions, and participating in group purchasing initiatives. These actions aim to optimize margins, ensure resilient supply chains, and maintain service continuity despite operational cost pressures.

Methodology & Data Sources

This market intelligence is built on primary research, including extensive executive interviews and structured surveys, complemented by thorough secondary review of policy documentation, academic research, and recognized industry publications. Analytical frameworks and validation protocols ensure insights delivered are both actionable and reliable for executive strategy development.

Why This Report Matters for Senior Leaders

• Enables benchmarking of hospice service capabilities and identification of growth opportunities tailored to specific regions and operational contexts.
• Supports refinement of business strategy through evidence-based analysis of innovative, patient-centered models and advancements in cost management.
• Guides procurement, workforce, and investment decisions with concise assessments of regulatory changes and tariff impacts across the sector.

Conclusion

The United States hospice care market is shaped by ongoing innovation, demographic changes, and evolving patient needs. Executives who leverage comprehensive market intelligence and adaptable, patient-focused strategies will be better prepared for growth and operational resilience amid increasing complexity.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.